- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
NTCP antibody detects Sodium/bile acid cotransporter (NTCP), encoded by the SLC10A1 gene on chromosome 14q24.1. NTCP antibody is commonly used in research focused on hepatic physiology, bile acid transport, and viral infection biology. NTCP is a sodium-dependent transporter located on the basolateral membrane of hepatocytes and functions as a key receptor for bile acids, driving their reuptake from portal blood into the liver. This process maintains enterohepatic circulation and bile acid homeostasis, supporting digestion, cholesterol metabolism, and signaling regulation. Beyond bile acid transport, NTCP has been identified as a critical receptor for hepatitis B virus (HBV) and hepatitis D virus (HDV), making it a central target in hepatology research.
Structurally, NTCP is a ~349 amino acid glycoprotein predicted to contain seven transmembrane domains, with extracellular loops that participate in ligand binding and viral recognition. Its sodium-binding sites couple transport of bile acids with sodium gradients, ensuring efficient uptake. NTCP is highly conserved across mammals, reflecting its essential physiological role. Expression is predominantly restricted to hepatocytes, where it is localized to the sinusoidal membrane, although lower levels have been detected in extrahepatic tissues.
Functionally, NTCP regulates bile acid transport by mediating uptake of conjugated bile salts such as taurocholate and glycocholate. By controlling hepatic bile acid flux, NTCP contributes to cholesterol catabolism, nutrient absorption, and metabolic signaling through bile acid-activated nuclear receptors like FXR and TGR5. NTCP also functions as the entry receptor for HBV and HDV, with viral preS1 domain binding to NTCP extracellular loops to initiate infection. Inhibition of NTCP prevents viral entry, making it a therapeutic target for antiviral strategies. Researchers use NTCP antibody to study bile acid metabolism, transporter biology, and viral pathogenesis.
Clinically, NTCP has major implications in hepatology and infectious disease. Mutations in SLC10A1 cause NTCP deficiency, a rare metabolic disorder characterized by elevated serum bile acid levels and neonatal hypercholanemia. NTCP polymorphisms influence susceptibility to HBV infection and disease progression. Pharmacological inhibition of NTCP by bile acid derivatives or drugs such as Myrcludex B (bulevirtide) is being investigated for treatment of HBV/HDV infection. Altered NTCP expression also contributes to cholestatic liver diseases and metabolic syndromes. NSJ Bioreagents offers NTCP antibody as a validated reagent for liver disease, viral infection, and transporter research.
Experimentally, NTCP antibody is applied in western blotting to detect the ~39 kDa protein, in immunofluorescence microscopy to visualize hepatocyte plasma membrane localization, and in immunohistochemistry to study liver tissue expression. Co-immunoprecipitation with NTCP antibody enables identification of viral binding partners and transport complexes. Functional assays combining NTCP antibody with transport inhibitors provide insights into bile acid flux and viral entry mechanisms.
Optimal dilution of the NTCP antibody should be determined by the researcher.
Amino acids EGLLFIIIFRCYLKIKPQKDQTKITYKAAATEDATPAALEK of mouse SLC10A1/NTCP were used as the immunogen for the NTCP antibody.
After reconstitution, the NTCP antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.